Cargando…
A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) became a global human health threat since its first documentation in humans in 2012. An efficient vaccine for the prophylaxis of humans in hotspots of the infection (e.g., Saudi Arabia) is necessary but no commercial vaccines are yet approved....
Autores principales: | Shehata, Mahmoud M., Kandeil, Ahmed, Mostafa, Ahmed, Mahmoud, Sara H., Gomaa, Mokhtar R., El-Shesheny, Rabeh, Webby, Richard, Kayali, Ghazi, A. Ali, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963271/ https://www.ncbi.nlm.nih.gov/pubmed/31810359 http://dx.doi.org/10.3390/pathogens8040281 |
Ejemplares similares
-
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science
por: Mostafa, Ahmed, et al.
Publicado: (2020) -
Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus Isolated from a Dromedary Camel in Egypt
por: Kandeil, Ahmed, et al.
Publicado: (2016) -
PA from a Recent H9N2 (G1-Like) Avian Influenza A Virus (AIV) Strain Carrying Lysine 367 Confers Altered Replication Efficiency and Pathogenicity to Contemporaneous H5N1 in Mammalian Systems
por: Mostafa, Ahmed, et al.
Publicado: (2020) -
We are underestimating, again, the true burden of H5N1 in humans
por: Gomaa, Mokhtar, et al.
Publicado: (2023) -
Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak
por: El-Shesheny, Rabeh, et al.
Publicado: (2022)